cagrisema vs semaglutide CagriSema- IN ADULTS WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES MELLITUS.pptx Cagrilintide–semaglutide (CagriSema) versus semaglutide or

The landmark SUSTAIN-6 trial demonstrated that semaglutide reduced the risk of major adverse cardiovascular events by approximately 26% compared to placebo over a median follow-up period of just over two years

Josie What I like: Strong focus on women's health from a hormonal care perspective Menopause and perimenopause support GLP-1 care alongside hormone-related care Education-focused approach A great option for women navigating midlife hormonal changes

Inter and intracellular mitochondrial trafficking in health and disease

Pancreatitis can cause pain in the upper stomach that may move to your back

56 : 407412 Goodwin FK, Jamison KR

Human trials are ongoing, particularly in the context of aging, Alzheimers disease, and cancer